Lead Product(s) : Peptide Based-pan Coronavirus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Valo Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Valo Tx, will use its proprietary PeptiVAX technology to coat a spike-expressing adenoviral vector vaccine with HLA-restricted peptides. These peptides may be associated with a clinically beneficial T cell immune responses to Sars-CoV-2's highly conserve...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
September 03, 2021
Lead Product(s) : Peptide Based-pan Coronavirus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Valo Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Flinders University
Deal Size : Undisclosed
Deal Type : Partnership
Proteona’s ESCAPE™ platform selected for SARS-CoV-2 vaccine characterization
Details : Proteona will use its ESCAPE™ technology to profile the immune response of patients receiving the vaccine. The technology will be used by Professor Petrovsky to characterize the clinical response to a new SARS-CoV-2 vaccine which is under investigatio...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
December 05, 2020
Lead Product(s) : SARS-CoV-2 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Flinders University
Deal Size : Undisclosed
Deal Type : Partnership